FDA Inspection
Patheon Pharmaceuticals Inc.Patheon Pharmaceuticals Inc. – FDA Inspection, Apr 21, 2023
Record Details
This FDA Inspection record concerns Patheon Pharmaceuticals Inc., with an inspection on April 21, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 3de4da01-f6e4-44da-9ab7-6f8f8d719fe2
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1204466
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Patheon Pharmaceuticals Inc.
16| Date | Classification | Office | Project area |
|---|---|---|---|
| September 26, 2025 | VAI | Cincinnati District Office | Drug Quality Assurance |
| July 24, 2023 | Not classified | Cincinnati District Office | |
| January 14, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 15, 2019 | OAI | Cincinnati District Office | Generic Drug Evaluation |
| February 14, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Patheon Pharmaceuticals Inc.
- FDA Inspection 1281564 - 2025-09-26
- FDA Inspection 1211249 - 2023-07-24
- FDA Inspection 1117783 - 2020-01-14
- FDA Inspection 1079809 - 2019-02-15
- FDA Inspection 1040994 - 2018-02-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.